FAQ: Recognizing OHE Risk in Patients with Chronic Liver Disease
Thank you to Salix for the support on this FAQ Video Module.This educational FAQ module, featuring Mikhail Alper, PA-C focuses on recognizing risk factors and early clinical indicators of Overt Hepati...
26 Mai 2min
FAQ: Phase 3 GALAXI 2 & 3: Extraintestinal Manifestations In Moderate to Severe Crohn’s Disease
Thank you to Johnson & Johnson for the support on this FAQ Video Module.This FAQ video features Janette Villalon, PA, who reviews the role of guselkumab in treating extraintestinal manifestations in p...
19 Mai 5min
Medication Review: Monotherapy vs. Combination Therapy: Relevance in IBD Treatment Strategy
Thank you to Celltrion for the support on this Medication Review Video Module.This medication review explores the evolving role of monotherapy versus combination therapy in the treatment of inflammato...
14 Mai 3min
Medication Review: Stable PK Supporting Continuous Inflammatory Control
Thank you to Celltrion for the support on this Medication Review Video Module.This medication review explores the role of stable pharmacokinetics (PK) in achieving continuous inflammatory control in i...
7 Mai 6min
Journal Club: ASTRO Phase 3 Study: Efficacy and Safety of SC Guselkumab
Thank you to Johnson & Johnson for the support on this Journal Club Review Module.In this journal club video, Sharon Dudley Brown, CRNP, PhD, from the IBD Center at Johns Hopkins University, reviews t...
28 Apr 5min
Podcast: How Do You Best Support Patients Getting Started on New MASH Treatments?
Learn how to effectively support patients starting treatment for MASH with this practical, clinician-focused discussion featuring expert advanced practice providers. In this episode, hepatology specia...
14 Apr 18min
Podcast: Best Practices For Patient Identification
Stay up to date on MASH and MASLD with expert insights from nurse practitioners Sarah Dawkins of Duke University Medical Center and Edith Johannes of UCLA Health. This episode focuses on best practice...
7 Apr 17min
